Differential Effects of Type I and II Interferons on Myeloid Cells and Resistance to Intracellular Bacterial Infections

Overview

Journal Immunol Res

Specialty Allergy & Immunology

Date 2012 Sep 18

PMID 22983898

Citations 17

Authors

Staci Kearney

Christine Delgado

Laurel L Lenz

Affiliations

Soon will be listed here.

Abstract

The type I and II interferons (IFNs) play important roles in regulating immune responses during viral and bacterial infections and in the context of autoimmune and neoplastic diseases. These two IFN types bind to distinct cell surface receptors that are expressed by nearly all cells to trigger signal transduction events and elicit diverse cellular responses. In some cases, type I and II IFNs trigger similar cellular responses, while in other cases, the IFNs have unique or antagonistic effects on host cells. Negative regulators of IFN signaling also modulate cellular responses to the IFNs and play important roles in maintaining immunological homeostasis. In this review, we provide an overview of how IFNs stimulate cellular responses. We discuss the disparate effects of type I and II IFNs on host resistance to certain intracellular bacterial infections and provide an overview of models that have been proposed to account for these disparate effects. Mechanisms of antagonistic cross talk between type I and II IFNs are also introduced.

Citing Articles

adapts its investment into replication transmission according to the host environment.

Abdi A, Achcar F, Sollelis L, Silva-Filho J, Mwikali K, Muthui M Elife. 2023; 12.

PMID: 36916164 PMC: 10059685. DOI: 10.7554/eLife.85140.

Transcriptional Profiling of Phagocytic Leukocytes and Microglia Reveals a Critical Role for Reactive Oxygen Species in Biofilm Containment during Staphylococcus aureus Craniotomy Infection.

Menousek J, Horn C, Heim C, Van Roy Z, Korshoj L, Kielian T J Immunol. 2022; 209(10):1973-1986.

PMID: 36426943 PMC: 9643635. DOI: 10.4049/jimmunol.2200503.

IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.

Maciag K, Raychowdhury R, Smith K, Schneider A, Coers J, Mumbach M J Leukoc Biol. 2021; 112(2):257-271.

PMID: 34826345 PMC: 9550582. DOI: 10.1002/JLB.3A0218-069RR.

Myeloid cell responsiveness to interferon-gamma is sufficient for initial resistance to .

Eshleman E, Bortell N, McDermott D, Crisler W, Lenz L Curr Res Immunol. 2021; 1:1-9.

PMID: 34337387 PMC: 8323841. DOI: 10.1016/j.crimmu.2020.01.001.

Oral Administration of Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout.

Santibanez A, Paine D, Parra M, Munoz C, Valdes N, Zapata C Front Immunol. 2021; 12:696803.

PMID: 34248997 PMC: 8268009. DOI: 10.3389/fimmu.2021.696803.

References

Humann J, Lenz L . Activation of naive NK cells in response to Listeria monocytogenes requires IL-18 and contact with infected dendritic cells. J Immunol. 2010; 184(9):5172-8. PMC: 2920760. DOI: 10.4049/jimmunol.0903759. View

MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

Sadler A, Williams B . Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008; 8(7):559-68. PMC: 2522268. DOI: 10.1038/nri2314. View

Cooper A . Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009; 27:393-422. PMC: 4298253. DOI: 10.1146/annurev.immunol.021908.132703. View

Carrero J, Calderon B, Unanue E . Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med. 2006; 203(4):933-40. PMC: 2118284. DOI: 10.1084/jem.20060045. View

Stark G, Kerr I, Williams B, Silverman R, Schreiber R . How cells respond to interferons. Annu Rev Biochem. 1998; 67:227-64. DOI: 10.1146/annurev.biochem.67.1.227. View

Nagarajan U, Prantner D, Sikes J, Andrews Jr C, Goodwin A, Nagarajan S . Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect Immun. 2008; 76(10):4642-8. PMC: 2546839. DOI: 10.1128/IAI.00629-08. View

Muhlethaler-Mottet A, Di Berardino W, Otten L, MACH B . Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity. 1998; 8(2):157-66. DOI: 10.1016/s1074-7613(00)80468-9. View

Eichbaum Q, Iyer R, Raveh D, Mathieu C, Ezekowitz R . Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med. 1994; 179(6):1985-96. PMC: 2191524. DOI: 10.1084/jem.179.6.1985. View

10.

Kurihara T, Warr G, Loy J, Bravo R . Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 1997; 186(10):1757-62. PMC: 2199145. DOI: 10.1084/jem.186.10.1757. View

11.

Thomas C, Moraga I, Levin D, Krutzik P, Podoplelova Y, Trejo A . Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell. 2011; 146(4):621-32. PMC: 3166218. DOI: 10.1016/j.cell.2011.06.048. View

12.

Wen Z, Zhong Z, Darnell Jr J . Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995; 82(2):241-50. DOI: 10.1016/0092-8674(95)90311-9. View

13.

Serbina N, Pamer E . Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006; 7(3):311-7. DOI: 10.1038/ni1309. View

14.

David M, Petricoin 3rd E, Benjamin C, Pine R, Weber M, Larner A . Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 1995; 269(5231):1721-3. DOI: 10.1126/science.7569900. View

15.

Parsa K, Butchar J, Rajaram M, Cremer T, Gunn J, Schlesinger L . Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Mol Immunol. 2008; 45(12):3428-37. PMC: 2577832. DOI: 10.1016/j.molimm.2008.04.006. View

16.

MacMicking J, Xie Q, Nathan C . Nitric oxide and macrophage function. Annu Rev Immunol. 1997; 15:323-50. DOI: 10.1146/annurev.immunol.15.1.323. View

17.

Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H . Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010; 23(2):75-93. DOI: 10.1016/j.niox.2010.04.007. View

18.

Dighe A, Campbell D, Hsieh C, Clarke S, Greaves D, Gordon S . Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity. 1995; 3(5):657-66. DOI: 10.1016/1074-7613(95)90136-1. View

19.

Stoiber D, Stockinger S, Steinlein P, Kovarik J, Decker T . Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3. J Immunol. 2000; 166(1):466-72. DOI: 10.4049/jimmunol.166.1.466. View

20.

Lemke G, Rothlin C . Immunobiology of the TAM receptors. Nat Rev Immunol. 2008; 8(5):327-36. PMC: 2856445. DOI: 10.1038/nri2303. View